Google
 
Google

World Stem Cell Summit 2010

Wednesday, July 30, 2008

Nature Clinical Practice Oncology - Table of Contents alert Volume 5 Issue 8

NATURE CLINICAL PRACTICE ONCOLOGY

August 2008 Volume 5 Number 8

Visit Nature Clinical Practice Oncology online to browse the journal.

Now available at http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0UgF0E3

=====================================================================

ESO e-grandround
http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0BrPN0EO

The European School of Oncology in partnership with Nature Clinical
Practice Oncology is pleased to announce live e-grandrounds. These
online discussion-based presentations allow participants to submit
questions and take part in lively discussions. We invite you to join
the e-grandrounds, which are broadcast every other Thursday from
17:15-18:00 GMT.

Please visit http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0BrPk0Er
for further information.

=====================================================================

----------------------
EDITORIAL
----------------------
Clinical evidence does not support the use of adjuvant radiotherapy in
pancreatic cancer
John P Neoptolemos
http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0B1q30EP

----------------------
RESEARCH HIGHLIGHTS
----------------------
CARD11-a new therapeutic target in activated B cell-like diffuse large
B-cell lymphoma
http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0B1q40EQ

Daily aspirin use is associated with a reduced risk of ER-positive breast
cancer
http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0B1q50ER

MicroRNA signature predicts outcome in acute myeloid leukemia
http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0B1q60ES

Mutations in patients with cytogenetically normal AML predict treatment
outcome
http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0B1q70ET

----------------------
PRACTICE POINTS
----------------------
Radiation therapy improves survival in patients with pancreatic
adenocarcinoma
Felix Y Feng and Edgar Ben-Josef
http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0B1q80EU

Bevacizumab plus interferon [alpha] in patients with metastatic renal
cell carcinoma
Przemyslaw Twardowski and Robert A Figlin
http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0B1rA0Ee

Adjuvant EBRT improves survival in patients with lymph-node-negative
pancreatic cancer
Lisa J Hazard, Jonathan D Tward and Dennis C Shrieve
http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0B1rB0Ef

The CCR9-CCL25 axis mediates melanoma metastasis to the small intestine
Joost van den Oord
http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0B1rC0Eg

----------------------
VIEWPOINT
----------------------
Who should receive myeloablative therapy for diffuse large B-cell
lymphoma?
Luciano Wannesson and Emanuele Zucca
http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0B1rD0Eh

----------------------
REVIEWS
----------------------
Chemotherapy for muscle-invasive bladder cancer treated with definitive
radiotherapy: persisting uncertainties
Toni K Choueiri and Derek Raghavan
http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0B1rE0Ei

Predictive factors for chemotherapy-related toxic effects in patients
with colorectal cancer
Bruno Vincenzi, Gaia Schiavon, Francesco Pantano, Daniele Santini and
Giuseppe Tonini
http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0B1rF0Ej

Do stress-related psychosocial factors contribute to cancer incidence and
survival?
Yoichi Chida, Mark Hamer, Jane Wardle and Andrew Steptoe
http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0B1rG0Ek

Mechanisms of Disease: temozolomide and glioblastoma-look to the future
Maciej M Mrugala and Marc C Chamberlain
http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0B1rH0El

----------------------
CASE STUDY
----------------------
Audiologic and radiographic response of NF2-related vestibular schwannoma
to erlotinib therapy
Scott R Plotkin, Marybeth A Singh, Caroline C O'Donnell, Gordon J Harris,
Andrea I McClatchey and Chris Halpin
http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0B1rI0Em

----------------------
CORRIGENDUM
----------------------
Lenalidomide plus dexamethasone is efficacious in patients with relapsed
or refractory multiple myeloma
Nikhil C Munshi, Constantine Mitsiades, Paul G Richardson and
Kenneth C Anderson
http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0B1rJ0En

----------------------
ERRATUM
----------------------
Prognosis and outcomes of lymphocyte-predominant Hodgkin's lymphoma
Grace Suh and Anas Younes
http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0B1rK0Eo

=====================================================================

Announcing the NEW British Journal of Cancer website with enhanced
functionality

Visit http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0f8c0E2
and benefit from new features, including RSS Web Feeds, Article Links
and Top Ten downloaded articles.

=====================================================================

You have been sent this Table of Contents Alert because you have opted
in to receive it. You can change or discontinue your e-mail alerts at
any time, by modifying your preferences on your nature.com account at:
http://ealerts.nature.com/cgi-bin24/DM/y/embU0Xztnp0HjM0Zzu0EF
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department:
registration@nature.com

For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com

For other enquiries, please contact our customer feedback department:
feedback@nature.com

Nature Publishing Group | 75 Varick Street, 9th Floor | New York |
NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston

=====================================================================

Google

Any Comments ?.......

E-mail: manojhind2001us@gmail.com
Google
 

World Time